Based on the limited literature from women with high familial risk or PV in BRCA1/2, exogenous hormones are not contraindicated in unaffected women, but patients with previous breast cancer (especially hormone receptor positive cancer) are advised against exogenous hormone use [59–63]. The gene discussed is BRCA1; the disease is breast carcinoma.